CV Sciences, Inc. to Present at 8th Annual LD Micro Invitational on June 4-6, 2018 in Bel-Air, California

San Diego, California, UNITED STATES


LAS VEGAS, May 22, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc., (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), preeminent manufacturer and distributor of the leading brand of hemp extract products, PlusCBD Oil™, announced today that it will be presenting at the 8th Annual LD Micro Invitational, being held at the Luxe Sunset Boulevard Hotel in Bel-Air, California on June 4-6, 2018.  

Joseph Dowling, Chief Financial Officer of CV Sciences, will deliver a corporate presentation covering the Company’s two distinct business segments: its hemp-based CBD products that are distributed to over 1,750 retail stores in the U.S. and #1 in sales in the nutraceuticals hemp CBD market; and its lead drug candidate (CVSI-007) which utilizes synthetically-formulated CBD for use in the treatment of smokeless tobacco addiction. Management will be available for one-on-one meetings with investors.

About LD Micro

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. LD Micro are investors, first and foremost.

What started out as a newsletter highlighting unique companies has transformed into several influential conferences annually (Invitational, Summit, and Main Event).

In 2015, LD Micro launched ldmicro.com as a portal to provide exclusive intraday information on the entire sector, including the first pure microcap index (LDMi) which covers stocks in North America with market capitalizations between $50-$300m.

About CV Sciences, Inc.

CV Sciences, Inc. (OTCQB:CVSI) operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD; and a consumer product division in manufacturing, marketing and selling plant-based CBD products to a range of market sectors. CV Sciences, Inc. has primary offices and facilities in San Diego, California and Las Vegas, Nevada. Additional information is available from OTCMarkets.com or by visiting www.cvsciences.com.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

CONTACT INFORMATION:

Robert Haag
Managing Director
IRTH Communications
CVSI@irthcommunications.com
866-976-4784